Kaitin KI - Search Results

1

The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.

Evens RP, Kaitin KI. Evens RP, et al. Among authors: kaitin ki. Clin Pharmacol Ther. 2014 May;95(5):528-32. doi: 10.1038/clpt.2014.14. Epub 2014 Jan 21. Clin Pharmacol Ther. 2014. PMID: 24448474

2

The evolution of biotechnology and its impact on health care.

Evens R, Kaitin K. Evens R, et al. Health Aff (Millwood). 2015 Feb;34(2):210-9. doi: 10.1377/hlthaff.2014.1023. Health Aff (Millwood). 2015. PMID: 25646100

3

Impact of the new US health-care-reform legislation on the pharmaceutical industry: who are the real winners?

Milne CP, Kaitin KI. Milne CP, et al. Among authors: kaitin ki. Clin Pharmacol Ther. 2010 Nov;88(5):589-92. doi: 10.1038/clpt.2010.167. Clin Pharmacol Ther. 2010. PMID: 20959844 Free PMC article.

4

Taking the pulse of strategic outsourcing relationships.

Getz KA, Lamberti MJ, Kaitin KI. Getz KA, et al. Among authors: kaitin ki. Clin Ther. 2014 Oct 1;36(10):1349-55. doi: 10.1016/j.clinthera.2014.09.008. Epub 2014 Oct 23. Clin Ther. 2014. PMID: 25444564

5

Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009.

Kaitin KI, DiMasi JA. Kaitin KI, et al. Clin Pharmacol Ther. 2011 Feb;89(2):183-8. doi: 10.1038/clpt.2010.286. Epub 2010 Dec 29. Clin Pharmacol Ther. 2011. PMID: 21191382 Review.

6

A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.

Selker HP, Cohen T, D'Agostino RB, Dere WH, Ghaemi SN, Honig PK, Kaitin KI, Kaplan HC, Kravitz RL, Larholt K, McElwee NE, Oye KA, Palm ME, Perfetto E, Ramanathan C, Schmid CH, Seyfert-Margolis V, Trusheim M, Eichler HG. Selker HP, et al. Among authors: kaitin ki. Clin Pharmacol Ther. 2022 Aug;112(2):224-232. doi: 10.1002/cpt.2425. Epub 2021 Oct 20. Clin Pharmacol Ther. 2022. PMID: 34551122 Free PMC article. Review.

7

The role of the research-based pharmaceutical industry in medical progress in the United States.

Kaitin KI, Bryant NR, Lasagna L. Kaitin KI, et al. J Clin Pharmacol. 1993 May;33(5):412-7. doi: 10.1002/j.1552-4604.1993.tb04680.x. J Clin Pharmacol. 1993. PMID: 8331197

8

Obstacles and opportunities in new drug development.

Kaitin KI. Kaitin KI. Clin Pharmacol Ther. 2008 Feb;83(2):210-2. doi: 10.1038/sj.clpt.6100462. Clin Pharmacol Ther. 2008. PMID: 18202685 No abstract available.

9

Deconstructing the drug development process: the new face of innovation.

Kaitin KI. Kaitin KI. Clin Pharmacol Ther. 2010 Mar;87(3):356-61. doi: 10.1038/clpt.2009.293. Epub 2010 Feb 3. Clin Pharmacol Ther. 2010. PMID: 20130565 Free PMC article. Review.

10

The drug lag: an update of new drug introductions in the United States and in the United Kingdom, 1977 through 1987.

Kaitin KI, Mattison N, Northington FK, Lasagna L. Kaitin KI, et al. Clin Pharmacol Ther. 1989 Aug;46(2):121-38. doi: 10.1038/clpt.1989.116. Clin Pharmacol Ther. 1989. PMID: 2758722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters